Coeptis Therapeutics Holdings Inc. Common Stock (COEP) Stock Price

COEPStock
$4.2371.73%52W
Market Cap
P/E
PEG Ratio
Div yield
Beta0.50

COEP Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-78.57%
Price vs S&P 500 (4W)-26.44%
VGM Score15.50

COEP Analyst Recommendations

Nov 2024
Dec 2024
Jan 2025
Feb 2025
2.17
2.17
2.17
2.17

Industry Peers — Finance Services(168)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
COEPCoeptis Therapeutics Holdings Inc. Common Stock
FD$4.23
AXPAmerican Express CompanyDBB$333.20
NUNu Holdings Ltd.DBC$14.30
MSTRStrategy Inc Common Stock Class ADDC$127.31
COINCoinbase Global, Inc. Class A Common StockDCC$178.64
SYFSYNCHRONY FINANCIALBCB$78.05
CRCLCircle Internet Group, Inc.DCC$87.14
SOFISoFi Technologies, Inc. Common StockDBC$18.06
BMNRBitMine Immersion Technologies, Inc.DAB$23.80
IRENIREN Limited Ordinary SharesFBC$35.45
CHYMChime Financial, Inc. Class A Common StockDBA$33.20

About Coeptis Therapeutics Holdings Inc. Common Stock

Coeptis Therapeutics develops cell therapy platforms for cancer patients. The company's pipeline includes SNAP-CAR, a multi-antigen CAR T technology licensed from the University of Pittsburgh, and CD38-GEAR-NK, a cell therapy candidate, along with a companion diagnostic. Coeptis collaborates with VyGen-Bio and the Karolinska Institutet on its CD38-targeted oncology programs.